TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | Time CapsuleSpectrumIn-DepthTravelFood
EntertainmentIPL 2025
Business | My MoneyAutoZone
UPSC | Exam ScheduleExam Mentor
Advertisement

Zydus, Lupin get USFDA nod for generic drugs

New Delhi, February 16 Zydus Lifesciences Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic Isosorbide Mononitrate extended-release tablets used to prevent chest pain in patients with a certain...
Advertisement

New Delhi, February 16

Zydus Lifesciences Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic Isosorbide Mononitrate extended-release tablets used to prevent chest pain in patients with a certain heart condition.

Advertisement

The US Food and Drug Administration (USFDA) has also given approval to Pharma major Lupin Ltd to market its generic ‘Minzoya’ tablets used to prevent pregnancy.

Advertisement
Show comments
Advertisement